Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
27.11.23
/
50%
€8.94
Target price
27.11.24
€11.87
Performance (%)
75.06%
Price
27.09.24
€15.65
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR has seen massive gains of 75.06%. This prediction currently runs until 27.11.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -0.318% | -0.318% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€16.90
03.09.24
03.09.24
€23.55
03.09.25
03.09.25
-7.40%
27.09.24
27.09.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.70
11.07.24
11.07.24
€22.04
11.07.25
11.07.25
-0.32%
27.09.24
27.09.24